![]() |
PHARMWORKS, LLC |
Home Search this site
|
Good Morning! My hosting service will be "upgrading my site in 10 minutes. No time for an editorial this week.... just news. Thanks to those who sent me book suggestions.... more later Have a GREAT week! Steve =================================================== ps. Best answer this week to the question "How are you?" was "I just couldn't ask for anything better because things are going so well. No sarcasm here!" pps. Please note that some of the links may not be up for very long and that you should capture or print anything that you may wish to keep. ------------
1) Compliance pays Patients who keep taking their “statins” cut their death rate. A 50% increase in compliance could cut death rate in half. If you die you will be 100% dead but if you live… now THAT is something else. http://www.nlm.nih.gov/medlineplus/news/fullstory_93997.html
2) Al Bundy Disease treatment? (Married with Children) Nags deficiency? Actually it is N acetyl glutamate synthetase, or NAGS, deficiency. FDA panel recommends approval of a drug to treat this inborn enzyme deficiency that causes a build up of ammonia in the blood. Don’t expect this to be used in too many of your patients when it is approved but I’m sure it will cost a pretty penny. http://www.reuters.com/article/idUSTRE60C61O20100113
3) More Chantix law suits Three cases allege suicidal activity because Pfizer did not notify docs quickly enough. (1 successful and 2 attempts) http://www.reuters.com/article/idUSN1417747120100115?type=marketsNews
4) ‘BamaCare wants to speed biogenerics The behind closed door meetings of Congress and the POTUS are likely to limit the exclusivity to biologics for the oriniating company. Another blow to development of new drugs would be struck. http://www.pharmalot.com/2010/01/an-11th-hour-battle-over-biogenerics-in-congress/
Click picture to learn about Hook or Crook Upscale, one-of-a-kind handbags accessories
5) Drug price hikes in anticipation of “BamaCare Increases in drug prices may be accelerating in anticipation of direct price negotiations between pharmaceutical companies and the government. http://www.reuters.com/article/idCNN1116984120100111?rpc=44
6) Spiriva manufacturer breaths a sigh of relief FDA finds Spiriva is as safe as placebo in controlled trials of cardiovascular risk of the pulmonary drug. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm197649.htm
7) Is it that we just can’t get any fatter? Rates of obesity are leveling off. Could it be that fat people are just dying off at a greater rate? Read more… http://www.bloomberg.com/apps/news?pid=20601202&sid=afYZWQDBI2Oo
Have a SUPER-FANTASTIC week. Steve --------------------------------------------------------------------------------------------------------------------------------------------------------------------
Disclaimer: "Pepin's Pharmaceutical Prattle" (AKA "The Prattle") is the property of PHARMWORKS, LLC and Steven M. Pepin, Pharm. D, BCPS. The opinions expressed are those of the bald-headed author. To start or stop any drug without the advice and supervision of your physician would be stupid. So don't do anything based upon what you read here without professional advice. To be added to or removed from the distribution list please e-mail your request to spepin@pharmworks.com . All insightful comments from readers are thoughtfully considered (the rest are callously discarded). Copyright 1998-2010 PHARMWORKS,LLC all rights reserved. Copyright 1998-2010 PHARMWORKS, LLC all rights reserved |